![](https://investorshub.advfn.com/uicon/140384.png?cb=1516314152)
Tuesday, January 30, 2018 1:01:21 PM
Recent RCKT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:17:36 PM
- Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress • Business Wire • 08/05/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:05:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/22/2024 07:22:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:05:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2024 07:17:34 PM
- Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI™ (marnetegragene autotemcel; marne-cel) • Business Wire • 06/28/2024 11:27:00 AM
- Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy • Business Wire • 05/29/2024 11:00:00 AM
- Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) • Business Wire • 05/10/2024 10:00:00 AM
- Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress • Business Wire • 05/06/2024 08:01:00 PM
- Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia • Business Wire • 04/02/2024 10:00:00 AM
- Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team • Business Wire • 03/26/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:54:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:48:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 08:54:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 07:59:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:37:50 PM
- Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress • Business Wire • 02/26/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 01:54:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 01:54:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 01:54:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 01:54:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 01:54:10 AM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 02/16/2024 10:28:42 PM
FEATURED POET Technologies Reports Second Quarter 2024 Financial Results • Aug 15, 2024 8:04 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
ATWEC Reaches Profitability, Announces Massive Earnings Growth, and a Strong Forecast for the Rest of 2024 • ATWT • Aug 15, 2024 7:16 AM